{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:06:06Z","timestamp":1794017166694,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eprac.2025.04.012","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T19:18:37Z","timestamp":1745608717000},"page":"956-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Low-Dose Tolvaptan for the Treatment of Syndrome of Inappropriate Antidiuretic Hormone\u2013Associated Hyponatremia: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Clinical Effectiveness and Safety"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9453-0975","authenticated-orcid":false,"given":"David","family":"Lewellyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thitikorn","family":"Nuamek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Ostarijas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Logan Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftychia E.","family":"Drakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.B.","family":"Aylwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6662-804X","authenticated-orcid":false,"given":"Georgios K.","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.eprac.2025.04.012_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7861\/clinmedicine.17-3-263","article-title":"Hyponatraemia - presentations and management","volume":"17","author":"Dineen","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.eprac.2025.04.012_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919877725","article-title":"Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study","volume":"11","author":"Berardi","year":"2019","journal-title":"Ther Adv Med Oncol"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.012_bib3","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-13-1020","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"170","author":"Spasovski","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.eprac.2025.04.012_bib4","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjmed.2009.01.027","article-title":"Mortality after hospitalization with mild, moderate, and severe hyponatremia","volume":"122","author":"Waikar","year":"2009","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.012_bib5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinternmed.2009.513","article-title":"Impact of hospital-associated hyponatremia on selected outcomes","volume":"170","author":"Wald","year":"2010","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.eprac.2025.04.012_bib6","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1007\/s12325-021-01947-9","article-title":"Using tolvaptan to treat hyponatremia: results from a post-authorization pharmacovigilance study","volume":"38","author":"Estilo","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.eprac.2025.04.012_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221097343","article-title":"The management of acute and chronic hyponatraemia","volume":"13","author":"Lawless","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2025.04.012_bib8","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1185\/03007995.2015.1072706","article-title":"\u2018Dos and don\u2019ts\u2019 in the management of hyponatremia","volume":"31","author":"Aylwin","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.eprac.2025.04.012_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231173327","article-title":"Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD)","volume":"14","author":"Tzoulis","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.eprac.2025.04.012_bib10","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.3390\/jcm12175483","article-title":"Safety and efficacy of vaptans in the treatment of hyponatremia from syndrome of inappropriate antidiuretic hormone secretion (SIADH): a systematic review and meta-analysis","volume":"12","author":"Krisanapan","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.eprac.2025.04.012_bib11","doi-asserted-by":"crossref","first-page":"977.e1","DOI":"10.1016\/j.amjmed.2011.04.028","article-title":"Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia","volume":"124","author":"Jaber","year":"2011","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.012_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ajkd.2010.01.013","article-title":"Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis","volume":"56","author":"Rozen-Zvi","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.012_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1507\/endocrj.EJ20-0216","article-title":"Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone","volume":"68","author":"Arima","year":"2021","journal-title":"Endocr J"},{"key":"10.1016\/j.eprac.2025.04.012_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40164-019-0128-y","article-title":"Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma","volume":"8","author":"O\u2019Connor-Byrne","year":"2019","journal-title":"Exp Hematol Oncol"},{"issue":"8","key":"10.1016\/j.eprac.2025.04.012_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2169\/internalmedicine.53.1440","article-title":"Prompt efficacy of tolvaptan in treating hyponatremia of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) closely associated with rupture of a gastric artery aneurysm","volume":"53","author":"Yamashita","year":"2014","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.012_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cen.12943","article-title":"Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion","volume":"84","author":"Tzoulis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.012_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.xkme.2019.09.004","article-title":"Equivalent efficacy and decreased rate of overcorrection in patients with syndrome of inappropriate secretion of antidiuretic hormone given very low-dose tolvaptan","volume":"2","author":"Hanna","year":"2019","journal-title":"Kidney Med"},{"issue":"11","key":"10.1016\/j.eprac.2025.04.012_bib18","doi-asserted-by":"crossref","first-page":"e4766","DOI":"10.1210\/clinem\/dgab131","article-title":"Clinical experience of the efficacy and safety of low-dose tolvaptan therapy in a UK tertiary oncology setting","volume":"106","author":"Chatzimavridou-Grigoriadou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.04.012_bib19","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa068","article-title":"Tolvaptan versus fluid restriction in the treatment of hyponatremia resulting from SIADH following pituitary surgery","volume":"4","author":"Kleindienst","year":"2020","journal-title":"J Endocr Soc"},{"issue":"7","key":"10.1016\/j.eprac.2025.04.012_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2169\/internalmedicine.56.7033","article-title":"Syndrome of inappropriate antidiuretic hormone secretion associated with amyotrophic lateral sclerosis in a patient developing carbon dioxide narcosis","volume":"56","author":"Inoue","year":"2017","journal-title":"Intern Med"},{"issue":"33","key":"10.1016\/j.eprac.2025.04.012_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020746","article-title":"Trimethoprim-sulfamethoxazole-induced hyponatremia in an elderly lady with Achromobacter xylosoxidans pneumonia: case report and insights into mechanism","volume":"99","author":"Ghali","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eprac.2025.04.012_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.689887","article-title":"Tolvaptan in the management of acute euvolemic hyponatremia after transsphenoidal surgery: a retrospective single-center analysis","volume":"12","author":"Indirli","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.012_bib23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s12325-020-01560-2","article-title":"Real-world, non-interventional, retrospective study (SAMPLE) of tolvaptan in patients with hyponatraemia secondary to the syndrome of inappropriate antidiuretic hormone secretion","volume":"38","author":"Pose-Reino","year":"2021","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.012_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3904\/kjim.2016.155","article-title":"Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience","volume":"33","author":"Park","year":"2018","journal-title":"Korean J Intern Med"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.012_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eprac.2024.12.019","article-title":"Efficacy and safety of low-dose tolvaptan (7.5 mg) in the treatment of inpatient hyponatremia: a retrospective study","volume":"31","author":"Llewellyn","year":"2025","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2025.04.012_bib26","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.eprac.2025.04.012_bib27","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.eprac.2025.04.012_bib28","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.eprac.2025.04.012_bib32","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1507\/endocrj.EJ23-0256","article-title":"A retrospective study on tolvaptan prescription in clinical practice in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) using the Japanese claims database","volume":"70","author":"Hagiwara","year":"2023","journal-title":"Endocr J"},{"issue":"2","key":"10.1016\/j.eprac.2025.04.012_bib33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12020-023-03457-w","article-title":"Long-term low-dose tolvaptan efficacy and safety in SIADH","volume":"82","author":"Bondanelli","year":"2023","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/j.eprac.2025.04.012_bib34","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00228-017-2302-7","article-title":"Low-dose tolvaptan PK\/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults","volume":"73","author":"Shoaf","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.eprac.2025.04.012_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10966","article-title":"Effect of vasopressin V2-receptor antagonist tolvaptan on syndrome of inappropriate antidiuresis (SIAD) after transsphenoidal pituitary surgery: recovery of measured osmolality","volume":"8","author":"Tosaka","year":"2022","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.eprac.2025.04.012_bib36","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1210\/clinem\/dgac245","article-title":"Approach to the patient: hyponatremia and the syndrome of inappropriate antidiuresis (SIAD)","volume":"107","author":"Martin-Grace","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.012_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.eprac.2025.04.012_bib31","author":"Harrer"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.012_bib37","first-page":"27","article-title":"Hyponatremia after trans-sphenoidal surgery","volume":"39","author":"Janneck","year":"2014","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2025.04.012_bib38","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.21037\/tcr-20-2123","article-title":"The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases","volume":"10","author":"Ren","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"7","key":"10.1016\/j.eprac.2025.04.012_bib39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11739-016-1508-5","article-title":"Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the Emergency Department","volume":"12","author":"Castello","year":"2017","journal-title":"Intern Emerg Med"},{"issue":"1","key":"10.1016\/j.eprac.2025.04.012_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/2042098610394233","article-title":"Management of hyponatraemia in older people: old threats and new opportunities","volume":"2","author":"Soiza","year":"2011","journal-title":"Ther Adv Drug Saf"},{"issue":"4","key":"10.1016\/j.eprac.2025.04.012_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0002-9629(15)40736-0","article-title":"The urine\/plasma electrolyte ratio: a predictive guide to water restriction","volume":"319","author":"Furst","year":"2000","journal-title":"Am J Med Sci"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:19:29Z","timestamp":1778224769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1530891X25001314"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.04.012","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Dose Tolvaptan for the Treatment of Syndrome of Inappropriate Antidiuretic Hormone\u2013Associated Hyponatremia: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Clinical Effectiveness and Safety","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}